Researchers at the Chemical Institute have developed a virtual ultrasound device that simulates the effects of ultrasound waves on soft biological structures. This innovation allows for more precise study of how ultrasound interacts with biological materials, which could lead to more effective targeted drug delivery therapies. The new method overcomes limitations of previous computational approaches by providing stable and realistic simulations in medical frequency ranges. Scientists used this tool to simulate acoustophoresis, the movement of microbubbles caused by ultrasound, enabling them to test interactions between ultrasound waves and biological structures before conducting physical experiments.
Bias read (Center): The article discusses scientific research and technological development without any political framing, bias, or controversy. It focuses purely on advancements in biomedical science and does not involve political actors, policies, or ideological perspectives.
Why factuality (85): The article reports on research conducted by scientists at the Chemical Institute, specifically the development of a virtual ultrasound device for simulating ultrasound wave interactions with biological structures. It aligns with the cross-source consensus that this technology aims to improve target
Why objectivity (78): The tone remains informative and focused on the scientific implications of the research. While there is some enthusiasm expressed regarding the potential benefits of the technology, the article avoids overtly emotional language or strong advocacy. However, it slightly leans towards highlighting the




